|
Market Closed -
Toronto S.E.
04:00:00 2026-10-26 pm EDT
|
5-day change | 1st Jan Change | ||
| 1.600 CAD | +0.63% |
|
+1.91% | +22.14% |
Company Valuation: Cardiol Therapeutics Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 142 | 43.96 | 71.77 | 151 | 130.4 | 185.7 | - | - |
| Change | - | -69.05% | 63.28% | 110.34% | -13.65% | 42.48% | - | - |
| Enterprise Value (EV) 1 | 142 | 43.96 | 36.84 | 120.4 | 108.9 | 166.7 | 179.2 | 185.7 |
| Change | - | -69.05% | -16.19% | 226.78% | -9.5% | 53.01% | 7.47% | 3.68% |
| P/E | -3.19x | -1.41x | -2.5x | -3.63x | -3.36x | -3.31x | -5.42x | -23.2x |
| PBR | - | - | 2.55x | 6.18x | 6.41x | 7.07x | 49.7x | - |
| PEG | - | 0x | 0.2x | -0.2x | 0.1x | -0.1x | 0.1x | 0.3x |
| Capitalization / Revenue | 1,803x | - | - | - | - | - | 111x | 3.52x |
| EV / Revenue | 1,803x | - | - | - | - | - | 107x | 3.52x |
| EV / EBITDA | -4.74x | -1.07x | -1.25x | -3x | -3.18x | -4.64x | -8.81x | -9.01x |
| EV / EBIT | -3.67x | -1.06x | -1.24x | -2.99x | -3.17x | -4.57x | -4.9x | -29.5x |
| EV / FCF | -6.03x | - | -1.46x | -4.8x | -4.56x | -5.35x | -5.73x | -2.87x |
| FCF Yield | -16.6% | - | -68.5% | -20.8% | -21.9% | -18.7% | -17.4% | -34.8% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -0.73 | -0.49 | -0.44 | -0.51 | -0.39 | -0.4804 | -0.2934 | -0.0685 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 0.0788 | - | - | - | - | - | 1.667 | 52.75 |
| EBITDA 1 | -29.95 | -41.12 | -29.54 | -40.11 | -34.21 | -35.9 | -20.34 | -20.62 |
| EBIT 1 | -38.66 | -41.34 | -29.79 | -40.28 | -34.32 | -36.49 | -36.54 | -6.288 |
| Net income 1 | -31.64 | -30.93 | -28.13 | -36.68 | -33.82 | -36.11 | -37.94 | -15.29 |
| Net Debt 1 | - | - | -34.93 | -30.58 | -21.42 | -19.05 | -6.594 | - |
| Reference price 2 | 2.330 | 0.690 | 1.100 | 1.850 | 1.310 | 1.590 | 1.590 | 1.590 |
| Nbr of stocks (in thousands) | 60,954 | 63,703 | 65,247 | 81,603 | 99,514 | 116,823 | - | - |
| Announcement Date | 3/23/22 | 3/28/23 | 4/1/24 | 3/31/25 | 3/31/26 | - | - | - |
1CAD in Million2CAD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.31x | - | -4.64x | - | 133M | |
| 18.83x | 6.63x | 13.18x | 1.58% | 64.69B | |
| 30.16x | 8x | 26.2x | 0.05% | 54.78B | |
| 36.79x | 6.53x | 19.51x | 0.88% | 53.49B | |
| 35.59x | 3.45x | 14.87x | -.--% | 45.98B | |
| 49.71x | 5.74x | 31.52x | -.--% | 42.94B | |
| -19.41x | 187.75x | -20.66x | -.--% | 40.08B | |
| 28.93x | 8.21x | 21.27x | 0.37% | 33.52B | |
| 27.67x | 5.83x | 15.12x | -.--% | 23.97B | |
| 32.59x | 5.97x | 20.28x | -.--% | 23.67B | |
| Average | 23.76x | 26.46x | 13.67x | 0.32% | 38.32B | |
| Weighted average by Cap. | 26.71x | 25.33x | 15.91x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CRDL Stock
- Valuation Cardiol Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
